Age- and sex-related changes in iliac cortical bone mass and remodeling.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 8274313)

Published in Bone on February 08, 1994

Authors

H Brockstedt1, M Kassem, E F Eriksen, L Mosekilde, F Melsen

Author Affiliations

1: University Department of Endocrinology and Metabolism, Aarhus Amtssygehus, Denmark.

Articles citing this

Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial. JAMA Intern Med (2015) 5.71

Bone quality: the material and structural basis of bone strength. J Bone Miner Metab (2008) 1.44

Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41

Animal models for fracture treatment in osteoporosis. Osteoporos Int (2005) 1.39

Impact on bone of an estrogen receptor-alpha gene loss of function mutation. J Clin Endocrinol Metab (2008) 1.12

Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. J R Soc Interface (2009) 1.06

Five-year DEXA study of 88 hips with cemented femoral stem. Int Orthop (2008) 0.91

Long-term prediction of three-dimensional bone architecture in simulations of pre-, peri- and post-menopausal microstructural bone remodeling. Osteoporos Int (2004) 0.90

Volumetric Cortical Bone Porosity Assessment with MR Imaging: Validation and Clinical Feasibility. Radiology (2015) 0.88

Determination of age at death using combined morphology and histology of the femur. J Anat (2000) 0.87

Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice. J Bone Miner Res (2014) 0.86

Loss of the osteogenic differentiation potential during senescence is limited to bone progenitor cells and is dependent on p53. PLoS One (2013) 0.86

Dependence of bone yield (volume of bone formed per unit of cement surface area) on resorption cavity size during osteonal remodeling in human rib: implications for osteoblast function and the pathogenesis of age-related bone loss. J Bone Miner Res (2010) 0.83

Thinking inside and outside the envelopes of bone: dedicated to PDD. Osteoporos Int (2009) 0.82

Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity. J Steroid Biochem Mol Biol (2009) 0.82

Age-related changes in iliac crest cortical width and porosity: a histomorphometric study. J Anat (2011) 0.81

Normalization of cortical bone density in children and adolescents with hyperthyroidism treated with antithyroid medication. Osteoporos Int (2011) 0.80

Age-related differences in volumetric bone mineral density, microarchitecture, and bone strength of distal radius and tibia in Chinese women: a high-resolution pQCT reference database study. Osteoporos Int (2015) 0.80

Age-related changes in bone remodelling and structure in men: histomorphometric studies. J Osteoporos (2011) 0.80

The effectiveness of bone mineral density as supplementary tool for evaluation of the osteogenic potential in patients with spinal fusion. Asian Spine J (2009) 0.78

MRI-derived bound and pore water concentrations as predictors of fracture resistance. Bone (2016) 0.76

Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects. Bonekey Rep (2015) 0.75

The effect of vitamin K2 on bone metabolism in aged female rats. Osteoporos Int (2005) 0.75

Articles by these authors

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA (1999) 9.05

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell (1999) 3.54

Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology (2001) 3.00

Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69

Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int (2006) 2.33

Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23

Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res (1996) 2.16

Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord (1998) 2.07

Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int (2000) 2.02

Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther (2007) 2.00

Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med (2000) 1.87

Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82

Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79

Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79

Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev (1986) 1.78

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78

Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2001) 1.70

Prognostic comparison of three classifications for medullary carcinomas of the breast. Histopathology (1997) 1.64

Experimental acute salpingitis in grivet monkeys provoked by Chlamydia trachomatis. Acta Pathol Microbiol Scand B (1979) 1.63

Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures. Eur J Clin Invest (2000) 1.62

A direct method for fast three-dimensional serial reconstruction. J Microsc (1990) 1.60

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57

Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int (2002) 1.53

Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49

Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am (1990) 1.47

Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. Bone Miner (1994) 1.47

Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47

Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest (2002) 1.46

Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone (1995) 1.45

Autosomal dominant osteopetrosis. Clin Orthop Relat Res (1993) 1.44

Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int (2010) 1.42

Familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) (1994) 1.42

Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41

[Vitamin D deficiency. Easy to diagnose, often overlooked]. Ugeskr Laeger (1999) 1.41

Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40

Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res (2001) 1.39

Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int (1989) 1.39

[Costs of different intervention strategies to prevent hip fractures]. Ugeskr Laeger (1999) 1.39

Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39

Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone (1996) 1.37

Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33

Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice. Calcif Tissue Int (2001) 1.32

Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30

Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone (2008) 1.30

Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest (2006) 1.29

The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab (1988) 1.29

The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res (1995) 1.29

Fracture risk in patients treated for hyperthyroidism. Thyroid (2000) 1.25

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res (1993) 1.24

Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone (1990) 1.23

Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22

Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut (1991) 1.21

Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone (2002) 1.20

Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int (2006) 1.18

Star volume of marrow space and trabeculae of the first lumbar vertebra: sampling efficiency and biological variation. Bone (1989) 1.18

Fractures in patients with primary idiopathic hypothyroidism. Thyroid (2000) 1.17

Human osteoblastic cells propagate intercellular calcium signals by two different mechanisms. J Bone Miner Res (2000) 1.17

Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone (1987) 1.17

Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone (1986) 1.16

Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A (1978) 1.16

The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol (1995) 1.16

Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int (2003) 1.14

Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res (1984) 1.14

Fracture risk is increased in epilepsy. Acta Neurol Scand (1999) 1.13

Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci U S A (1989) 1.13

Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res (1978) 1.12

Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int (1999) 1.12

Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone (1996) 1.11

Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem Biophys Res Commun (2005) 1.10

Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone (1999) 1.10

Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone (1986) 1.10

A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone (1997) 1.09

Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women. Eur J Clin Nutr (2012) 1.09

Treatment of cervical disc disease using Cloward's technique. I. General results, effect of different operative methods and complications in 1,106 patients. Acta Neurochir (Wien) (1984) 1.09